Miraculins Inc. announced its plans to add to its suite of maternal health biomarkers under license from Mount Sinai Hospital's Samuel Lunenfeld Research Institute by signing a term sheet to license methods and reagents for detecting hydroxylated Hypoxia Inducible Factor 1 alpha, a promising biomarker with potential in differentiating high and low risk pregnancies, including risk of preeclampsia. The technology is part of the pioneering research on preeclampsia and placental development being conducted by Dr. Isabella Caniggia, Senior Investigator at the Samuel Lunenfeld Research Institute, in collaboration with Dr. Martin Post, a Senior Scientist at The Hospital for Sick Children. Dr. Caniggia is also a member of Miraculins' Scientific Advisory Board and is cross-appointed at the University of Toronto as a Professor in Obstetrics and Gynecology as well as Physiology. In addition to its promise in maternal health and preeclampsia, HIF-1aOH also presents an opportunity as a cancer biomarker and of further note, the license will include unique monoclonal antibodies highly sensitive to HIF-1aOH and the exclusive rights to manufacture reagents that measure the biomarker using materials developed by Dr. Caniggia.

The Mount Sinai Medical Center announced that David L. Reich, MD, has been named Interim President of The Mount Sinai Hospital. Mr. Wayne Keathley has stepped down as President and Chief Operating Officer of The Mount Sinai Hospital to become President of Baylor College of Medicine Medical Center and Health Network in Houston, TX. Dr. Reich has been on the Appointments and Promotions Committee at Mount Sinai for the past 10 years, and has served on the Executive Committee of Mount Sinai Doctors Faculty Practice for eight years. He also serves as President of the Medical Board and has been keenly focused on strategic improvements in Hospital, School, and Faculty Practice operations over the past decade.

Mount Sinai Hospital Presents at 2011 Hospital & Healthcare I.T. Conference, Sep-28-2011 . Venue: Phoenix, Arizona, United States. Speakers: Susan Knox.